FDA: Balloon angioplasty catheters can reach market via 510(k) route

09/13/2010 | Medical Devices Today

The FDA issued a ruling saying manufacturers of balloon-tipped coronary angioplasty catheters can bring these products to market via the 510(k) process, rather than the premarket approval procedure, effective Oct. 8. The move is in line with the agency's decision to reclassify percutaneous transluminal coronary angioplasty catheters from Class III to Class II devices with corresponding special requirements.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN